<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Freiburg skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Freiburg</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="flex-container1"><DIV class="flex-item2"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/Introduction">Overview</A><A href="https://2017.igem.org/Team:Freiburg/Motivation">Motivation</A><A href="https://2017.igem.org/Team:Freiburg/CAR">CAR T Cells</A><A href="https://2017.igem.org/Team:Freiburg/Tumor_microenvironment">Tumor Microenvironment</A><A href="https://2017.igem.org/Team:Freiburg/Design">AND Gate</A><A href="https://2017.igem.org/Team:Freiburg/Outlook">Outlook</A><A href="https://2017.igem.org/Team:Freiburg/Achievements">Achievements</A><A href="https://2017.igem.org/Team:Freiburg/References">References</A></DIV></DIV></DIV><DIV class="flex-item3"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/Team">Members</A><A href="https://2017.igem.org/Team:Freiburg/Attributions">Attributions</A><A href="https://2017.igem.org/Team:Freiburg/Sponsors">Partners</A><A href="https://2017.igem.org/Team:Freiburg/Contact">Contact</A></DIV></DIV></DIV><DIV class="flex-item4"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/Results">Main Project</A><A href="https://2017.igem.org/Team:Freiburg/Model">Modeling</A><A href="https://2017.igem.org/Team:Freiburg/Applied_Design">Applied Design</A><A href="https://2017.igem.org/Team:Freiburg/Demonstrate">Proof of Concept</A><A href="https://2017.igem.org/Team:Freiburg/Basic_Part">BioBricks Basic Part</A><A href="https://2017.igem.org/Team:Freiburg/Improve">BioBrick Improvement</A><A href="https://2017.igem.org/Team:Freiburg/InterLab">Interlab Study</A></DIV></DIV></DIV><DIV class="flex-item5"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/Safety">Safety</A><A href="https://2017.igem.org/Team:Freiburg/Cloning">Cloning</A><A href="https://2017.igem.org/Team:Freiburg/Lab_Knockout"><I>HIF1A</I> Knockdown</A><A href="https://2017.igem.org/Team:Freiburg/Cell_culture">Cell Culture</A><A href="https://2017.igem.org/Team:Freiburg/Notebook">Lab Book</A></DIV></DIV></DIV><DIV class="flex-item6"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/HP/Silver">Human Practice</A><A href="https://2017.igem.org/Team:Freiburg/HP/Gold_Integrated">Integrated Human Practice</A><A href="https://2017.igem.org/Team:Freiburg/Collaborations">Collaborations</A></DIV></DIV></DIV></DIV><DIV class="body"><DIV class="cool_container"><UL class="circle-container"><LI><DIV id="box1" class="topicboxes"><DIV class="cool_image_blink element1"><DIV class="cool_content cool_text_blink link_trigger" href="https://2017.igem.org/Team:Freiburg/Achievements" title=""><DIV class="text">
            Besides learning  a lot and having fun, we achieved something great this year!
Check it out!

          </DIV></DIV></DIV><DIV class="cool_header"><A href="https://2017.igem.org/Team:Freiburg/Achievements">Achievements</A></DIV></DIV></LI><LI><DIV id="box2" class="topicboxes"><DIV class="cool_image_blink element2"><DIV class="cool_content cool_text_blink link_trigger" href="https://2017.igem.org/Team:Freiburg/Team" title="">Find out more  about the Freiburg 2017 team and our members!
          </DIV></DIV><DIV class="cool_header"><A href="https://2017.igem.org/Team:Freiburg/Team">Team</A></DIV></DIV></LI><LI><DIV id="box3" class="topicboxes"><DIV class="cool_image_blink element3"><DIV class="cool_content cool_text_blink link_trigger" href="https://2017.igem.org/Team:Freiburg/Design" title="AND gate">
            To make our approach safer, we are integrating two inputs into one output. Have a look!

          </DIV></DIV><DIV class="cool_header"><A href="https://2017.igem.org/Team:Freiburg/Design">AND Gate</A></DIV></DIV></LI><LI><DIV id="box4" class="topicboxes"><DIV class="cool_image_blink element4"><DIV class="cool_content cool_text_blink link_trigger" href="https://2017.igem.org/Team:Freiburg/Results" title="">
                  We generated  stable cell lines, a gene knockdown, characterized several promoters and much more!
              </DIV></DIV><DIV class="cool_header"><A href="https://2017.igem.org/Team:Freiburg/Results">Results</A></DIV></DIV></LI><LI><DIV id="box5" class="topicboxes"><DIV class="cool_image_blink element5"><DIV class="cool_content cool_text_blink link_trigger" href="https://2017.igem.org/Team:Freiburg/Model" title="">
               To better  understand our AND gate, we modeled gene expression within our genetic circuit.
            </DIV></DIV><DIV class="cool_header"><A href="https://2017.igem.org/Team:Freiburg/Model">Modeling</A></DIV></DIV></LI><LI><DIV id="box6" class="topicboxes"><DIV class="cool_image_blink element6"><DIV class="cool_content cool_text_blink link_trigger" href="https://2017.igem.org/Team:Freiburg/HP/Silver" title="">
                To hear thoughts about our project, check out our survey and interviews with experts working on the topic!
            </DIV></DIV><DIV class="cool_header"><A href="https://2017.igem.org/Team:Freiburg/HP/Silver">Human Practice</A></DIV></DIV></LI></UL></DIV></DIV><DIV class="container"><DIV class="row"><DIV class="col-md-12 text-center"><DIV class="flex-container" style="margin-top:-20%;padding-right:10%;"><DIV class="item"><H2 style="font-size:40px; padding-top: 50px" align="center">Abstract</H2><P>A new approach to cancer treatment is the chimeric antigen receptor (CAR) T cell therapy, which shows promising results fighting tumors in clinical trials. It consists of autologous isolated T cells modified with a chimeric receptor based on the T-cell receptor combined with the recognition domain of an antibody. Upon reinjection, CAR T cells exhibit cytotoxicity with high affinity towards cells displaying the antigen. However, clinical trials have shown that as tumor antigens are not solely expressed on tumor cells, but also on healthy tissues, grave off-target effects like the Graft-versus-Host-Disease may occur. In order to avoid such side-effects, we engineer CAR T cell lines specifically activated by factors of the tumor microenvironment. Controlled by a genetic AND gate system the T cells need two input signals in order to express CAR. This would allow highly localized cytotoxic activity of T cells and provide safer cell-based cancer immunotherapy especially for solid tumors.</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>